Adjuvant therapy in type 1 diabetes mellitus - choice or necessity in the COVID-19 pandemic?

Endokrynol Pol. 2021;72(2):89-90. doi: 10.5603/EP.a2021.0022.

Author

Edyta Cichocka¹

Affiliation

¹ Department of Internal Medicine, Diabetology, and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. [email protected].

PMID: 33970478
DOI: 10.5603/EP.a2021.0022

No abstract available

MeSH terms

COVID-19 / epidemiology
COVID-19 / therapy*
Diabetes Mellitus, Type 1 / epidemiology
Diabetes Mellitus, Type 1 / therapy*
Disease Management
Glycemic Control
Health Behavior
Humans
Telemedicine / organization & administration*